These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 17308095

  • 1. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
    Jungert K, Buck A, von Wichert G, Adler G, König A, Buchholz M, Gress TM, Ellenrieder V.
    Cancer Res; 2007 Feb 15; 67(4):1563-70. PubMed ID: 17308095
    [Abstract] [Full Text] [Related]

  • 2. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L, Hill CS.
    Mol Cell Biol; 2005 Sep 15; 25(18):8108-25. PubMed ID: 16135802
    [Abstract] [Full Text] [Related]

  • 3. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
    Ungefroren H, Sebens S, Groth S, Gieseler F, Fändrich F.
    Int J Oncol; 2011 Mar 15; 38(3):797-805. PubMed ID: 21225226
    [Abstract] [Full Text] [Related]

  • 4. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
    Jungert K, Buck A, Buchholz M, Wagner M, Adler G, Gress TM, Ellenrieder V.
    Carcinogenesis; 2006 Dec 15; 27(12):2392-401. PubMed ID: 16714330
    [Abstract] [Full Text] [Related]

  • 5. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.
    Clin Cancer Res; 2009 May 15; 15(10):3557-67. PubMed ID: 19447876
    [Abstract] [Full Text] [Related]

  • 6. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P.
    Cancer Res; 2006 Feb 15; 66(4):2202-9. PubMed ID: 16489022
    [Abstract] [Full Text] [Related]

  • 7. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC.
    Carcinogenesis; 2008 Feb 15; 29(2):252-62. PubMed ID: 17999987
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
    Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, Ellis LM.
    Cancer Res; 2006 Jan 01; 66(1):46-51. PubMed ID: 16397214
    [Abstract] [Full Text] [Related]

  • 9. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
    Räsänen K, Vaheri A.
    J Dermatol Sci; 2010 May 01; 58(2):97-104. PubMed ID: 20399617
    [Abstract] [Full Text] [Related]

  • 10. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T, Miyazono K.
    Cancer Res; 2009 Apr 01; 69(7):2783-91. PubMed ID: 19293183
    [Abstract] [Full Text] [Related]

  • 11. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
    Lee HS, Kim C, Kim SB, Kim MG, Park D.
    Biochem Biophys Res Commun; 2010 May 14; 395(4):553-9. PubMed ID: 20398629
    [Abstract] [Full Text] [Related]

  • 12. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A, Ijichi H, Kanai F, Imamura T, Guleng B, Ohta M, Imamura J, Tanaka Y, Tateishi K, Ikenoue T, Kawakami T, Arakawa Y, Miyagishi M, Taira K, Kawabe T, Omata M.
    Oncogene; 2005 Jan 20; 24(4):662-71. PubMed ID: 15592526
    [Abstract] [Full Text] [Related]

  • 13. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE, Cantin C, Nantel A, Wang E, Durocher Y, Banville M, Paul-Roc B, Marcil A, Wilson MR, O'Connor-McCourt MD.
    Oncogene; 2010 Feb 11; 29(6):831-44. PubMed ID: 19935703
    [Abstract] [Full Text] [Related]

  • 14. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
    Nam EH, Lee Y, Park YK, Lee JW, Kim S.
    Carcinogenesis; 2012 Mar 11; 33(3):563-71. PubMed ID: 22227038
    [Abstract] [Full Text] [Related]

  • 15. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling.
    Kong B, Michalski CW, Hong X, Valkovskaya N, Rieder S, Abiatari I, Streit S, Erkan M, Esposito I, Friess H, Kleeff J.
    Oncogene; 2010 Sep 16; 29(37):5146-58. PubMed ID: 20581862
    [Abstract] [Full Text] [Related]

  • 16. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW.
    Cancer Res; 2001 Aug 15; 61(16):6239-47. PubMed ID: 11507078
    [Abstract] [Full Text] [Related]

  • 17. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
    Liu X.
    Cell Motil Cytoskeleton; 2008 Dec 15; 65(12):935-44. PubMed ID: 18792103
    [Abstract] [Full Text] [Related]

  • 18. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A, Buchholz M, Wagner M, Adler G, Gress T, Ellenrieder V.
    Mol Cancer Res; 2006 Nov 15; 4(11):861-72. PubMed ID: 17114344
    [Abstract] [Full Text] [Related]

  • 19. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
    Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, Kawaguchi Y, Fujimoto K, Hosotani R, Imamura M.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4125-33. PubMed ID: 15217949
    [Abstract] [Full Text] [Related]

  • 20. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line.
    Hamada S, Satoh K, Hirota M, Kimura K, Kanno A, Masamune A, Shimosegawa T.
    J Cell Physiol; 2007 Dec 15; 213(3):768-74. PubMed ID: 17516553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.